Page last updated: 2024-11-11

7-hydroxy-4-trifluoromethylcoumarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-hydroxy-4-trifluoromethylcoumarin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5375667
CHEMBL ID104679
SCHEMBL ID307508
MeSH IDM0223893

Synonyms (46)

Synonym
STK723044
nsc-138174
575-03-1
nsc138174
4-trifluoromethylumbelliferone
7-hydroxy-4-(trifluoromethyl)chromen-2-one
7-hydroxy-4-trifluoromethylcoumarin
7-hydroxy-4-(trifluoromethyl)coumarin, 98%
MAYBRIDGE1_006885 ,
7,4-hfc
inchi=1/c10h5f3o3/c11-10(12,13)7-4-9(15)16-8-3-5(14)1-2-6(7)8/h1-4,14
HMS561A21
CHEMBL104679 ,
7-hydroxy-4-trifluoromethyl-chromen-2-one
7-hydroxy-4-(trifluoromethyl)-2h-chromen-2-one
bdbm50305310
AKOS001044552
A8197
7-hydroxy-4-(trifluoromethyl)coumarin
4-(trifluoromethyl)umbelliferone
7-hydroxy-4-(trifluoromethyl)-2h-1-benzopyran-2-one
BBL010638
2h-1-benzopyran-2-one, 7-hydroxy-4-(trifluoromethyl)-
nsc 138174
FT-0621421
AM20061185
c10h5f3o3
SCHEMBL307508
4-trifluoromethyl-7-hydroxycoumarin
FS-1127
H1422
J-100243
7-hydroxy-4-(trifluoromethyl)-2h-chromen-2-one #
2h-benzopyran-2-one, 7-hydroxy-4-(trifluoromethyl)-
tfmu
DTXSID80206109
mfcd00037578
CCG-245903
Z56895672
beta-trifluoromethylumbelliferone
EN300-05279
BB 0301290
T72647
CS-0010058
PD171465
SY048711
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)IC50 (µMol)0.19000.00261.76469.3000AID452459
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
NPYLR7BAedes aegypti (yellow fever mosquito)EC50 (µMol)6.31000.03902.289918.3000AID1259426
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
androgen biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
male genitalia developmentTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
steroid biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
estradiol 17-beta-dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone 17-beta-dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
17-beta-hydroxysteroid dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulum membraneTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
intracellular membrane-bounded organelleTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1472423Stability in human hepatocytes after 120 mins by HPLC-MS/MS analysis2018Journal of medicinal chemistry, 01-11, Volume: 61, Issue:1
The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity.
AID593513Binding affinity to corpus collosum myelin in central nervous system of mouse at 100 uM after 20 mins by fluorescent microscopy2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.
AID452459Inhibition of human 17beta-HSD3 expressed in HeLa cells2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Coumarins as novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer.
AID25853Photostability, pKa was evaluated1998Bioorganic & medicinal chemistry letters, Nov-17, Volume: 8, Issue:22
Synthesis of novel fluorinated coumarins: excellent UV-light excitable fluorescent dyes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's4 (25.00)29.6817
2010's9 (56.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.57 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index20.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]